Definitive Contract 75N93024C00039
Award Date
9/1/24
Potential Completion Date
8/31/26
Potential Value
$593K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Avantgen Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,497,384.00 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Avantgen Inc., a small business biotechnology company based in San Diego, California. The contract is for the development of rabbit monoclonal antibodies for use as ferret biomarkers. This contract is not associated with a larger contract vehicle and does not have a set-aside designation. Avantgen Inc. has previously been awarded multiple federal...
This is a $356,021 firm-fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Avantgen Inc., a San Diego-based biotechnology company. The contract is for the development of rabbit monoclonal antibodies for ferret biomarkers. This work is set aside for small businesses. Avantgen has previously received NIH contracts to develop rapid diagnostic...
This is a $747,441.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute to Avantgen Inc., a small business based in San Diego, CA. The contract is for a Small Business Innovation Research (SBIR) Phase II project titled "Recombinant Antibodies as Affinity Captures" under Topic 288. The goal is to develop recombinant antibodies for use in affinity capture applications. This contract builds upon Avantgen's prior SBIR Phase I and II awards from the National...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Abviro LLC, a for-profit limited liability company, on September 19, 2016. The contract is for the development of a broad-spectrum antibody therapeutic against flavivirus infections, with a ceiling value of $29,404,716.25 and a completion date of September 30, 2022. The contract type is a Definitive Contract with a Cost Plus Fixed Fee pricing...
This is a $2,517,650 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Battelle Memorial Institute. The contract is for the "SIDE-BY-SIDE EVALUATION OF FOUR ANTI-PROTECTIVE ANTIGEN MONOCLONAL ANTIBODIES IN THE NHP ADDED BENEFIT ANIMAL MODEL" and is issued under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ contract vehicle. Battelle will be the...
This is a $4,626,893.20 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute. The contract is for the evaluation of filovirus vaccines in general use prophylaxis (GUP) immunogenicity and filovirus challenge studies. Key subcontractors include Integrated Biotherapeutics, LLC, a small disadvantaged business, which provided services related to filovirus...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute, a nonprofit research and development organization. The $2,221,940.37 delivery order contract is for preparedness and testing of NIAID priority vaccines in general safety and toxicology studies. It does not have a set-aside designation. Battelle has subcontracted portions of the work to Envigo Global...
This federal contract award is for $17,568 to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The contract is for monoclonal antibodies and plasmids services to support biomedical research and public health initiatives. While the contract does not have a set-aside designation, Genscript has received other prime and...
This is a $164,700 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support critical research initiatives, with a period of performance through June 15, 2026. While the contract does not have a set-aside...
This firm fixed-price purchase order, valued at $16,215, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has received numerous prime...